Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C.

Anna H SchmitzKelly E WoodElliot L BurghardtBryan P KoestnerLinder H WendtAditya V BadhekaAnjali A Sharathkumar

Published in: Research and practice in thrombosis and haemostasis (2022)

Our experience of using clinically directed thromboprophylaxis with tailored intensity approach for children hospitalized with COVID-19 and MIS-C favors its inclusion in current standard of care. The role of D-dimer in directing thromboprophylaxis management deserves further evaluation.

Keyphrases

coronavirus disease
venous thromboembolism
sars cov
direct oral anticoagulants
young adults
healthcare
palliative care
chronic pain
health insurance